{"id":17908,"date":"2021-04-29T09:38:20","date_gmt":"2021-04-29T07:38:20","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=17908"},"modified":"2022-09-28T14:04:15","modified_gmt":"2022-09-28T12:04:15","slug":"kry-secures-over-usd-300-million-in-equity-financing-to-accelerate-european-expansion-plans","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/en\/assignment\/kry-secures-over-usd-300-million-in-equity-financing-to-accelerate-european-expansion-plans\/","title":{"rendered":"Kry secures over USD 300 million in equity financing"},"content":{"rendered":"<p class=\"preamble-large preamble\">Kry, operating as Livi in the UK and France, is the European leader in digital healthcare, whose technology connects patients with qualified healthcare professionals.<\/p>\n<p>Kry has secured over USD 300 million (EUR 262 million) in equity financing in a financing round led by CPP Investments (CPPIB) and Fidelity Management &amp; Research LLC with participation from existing shareholders, including the Ontario Teachers&#8217; Pension Plan, Index Ventures, Accel, Creandum and Project A.<\/p>\n<p>Kry will use the investment proceeds to scale its platform, building on both its operations as a healthcare provider and its innovative software offerings as well as further geographic expansion. This will bring the benefits of its technology to millions more patients across Europe.<\/p>\n<p>Kry was advised by Mannheimer Swartling in the transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kry, operating as Livi in the UK and France, is the European leader in digital healthcare, whose technology connects patients with qualified healthcare professionals. Kry\u2026<\/p>\n","protected":false},"author":9,"featured_media":17919,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4313],"tags":[],"class_list":["post-17908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-assignment","business-group-emerging-and-growth-companies","business-group-funds-and-investments","business-group-healthcare-and-life-sciences","business-group-mergers-and-acquisitions"],"acf":[],"lang":"en","translations":{"en":17908,"sv":17901},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/17908"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=17908"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/17908\/revisions"}],"predecessor-version":[{"id":17914,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/17908\/revisions\/17914"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media\/17919"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=17908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=17908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=17908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}